CLAYTON MCGINNIS: Open Payments
NPI 1750910931 · BRATTLEBORO, VT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,633 in 81 payments from 26 companies in 2025. Trend: 2023 $1,511 · 2024 $2,056 · 2025 $1,633
Food & beverage: $1,633
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 7 | $160 |
| Novartis Pharmaceuticals Corporation | 9 | $159 |
| Celgene Corporation | 10 | $152 |
| Janssen Biotech, Inc. | 8 | $142 |
| E.R. Squibb & Sons, L.L.C. | 5 | $94 |
| Deciphera Pharmaceuticals Inc. | 4 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $82 |
| ABBVIE INC. | 4 | $78 |
| Genentech USA, Inc. | 3 | $67 |
| Incyte Corporation | 3 | $67 |
Products named: KEYTRUDA, REBLOZYL, OPDIVO, QINLOCK, SCEMBLIX, EPKINLY, BRAFTOVI, KISQALI.
Industry payments across VT — which companies pay providers there.
